Biodesix Inc (BDSX)

$8.54 +0.40 (4.91%)
Market Cap 62.29M
Revenue (ttm) 71.32M
Net Income (ttm) -42.93M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -60.19%
Debt to Equity Ratio -27.40
Volume 59,700
Avg Vol 155,648
Day's Range N/A - N/A
Shares Out 7.96M
Stochastic %K 90%
Beta 0.62
Analysts Strong Sell
Price Target $33.33

Company Profile

Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy,...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 303 417 0500
Fax: 866 432 3338
Address:
919 West Dillon Road, Louisville, United States
Crypto9999
Crypto9999 Dec. 3 at 5:21 PM
$BDSX *Ultra-small float under 4 mil shares * Insiders hold 52.1% * Shorts have been covering * Active roadshows, ie NACLC * Growing their salesforce * Potential Suitors: Thermo Fisher Scientific Roche Diagnostics QIAGEN Becton, Dickinson and company Labcorp A buyout could fetch a 5-10X plus from here....
0 · Reply
RogerBarfield374
RogerBarfield374 Dec. 3 at 1:33 PM
$BDSX Biodesix To Present Data On Development Of New Ultra-Sensitive ESR1 Test For Initial Detection And Monitoring Of Mutations In HR+/HER2- Advanced Breast Cancers At SABCS
0 · Reply
Iightning
Iightning Nov. 26 at 6:02 AM
1ightning® Options Trade Alert (Actionable) | Buy $BDSX Jan 16 $8 Call | Enter: $0.05 Exit: $0.08 | Profit: 67.96% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 4:10 PM
1ightning® Options Trade Alert (Actionable) | Buy $BDSX Jan 16 $8 Call | Enter: $0.05 Exit: $0.08 | Profit: 67.96% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 5:04 AM
1ightning® Options Trade Alert (Actionable) | Buy $BDSX Jan 16 $8 Call | Enter: $0.05 Exit: $0.08 | Profit: 67.96% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 22 at 2:15 AM
1ightning® Options Trade Alert (Actionable) | Buy $BDSX Jan 16 $8 Call | Enter: $0.05 Exit: $0.10 | Profit: 90.69% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 21 at 5:37 AM
1ightning® Options Trade Alert (Actionable) | Buy $BDSX Jan 16 $8 Call | Enter: $0.05 Exit: $0.10 | Profit: 90.69% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 20 at 3:31 AM
1ightning® Options Trade Alert (Actionable) | Buy $BDSX Jan 16 $8 Call | Enter: $0.05 Exit: $0.10 | Profit: 90.69% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 19 at 11:13 AM
1ightning® Options Trade Alert (Actionable) | Buy $BDSX Jan 16 $8 Call | Enter: $0.05 Exit: $0.10 | Profit: 90.69% ROI | https://1ightning.com
0 · Reply
NVDAMillionaire
NVDAMillionaire Nov. 18 at 6:52 AM
$BDSX Brilliant piece that captures BDSX's situation perfectly. So if you want to update your understanding of BDSX or get to know BDSX better, this is essential reading. https://beyondspx.com/quote/BDSX/analysis/biodesix-unlocking-lung-health-s-potential-on-a-path-to-profitability-nasdaq-bdsx
0 · Reply
Latest News on BDSX
Biodesix to Present New Data at Two Major Upcoming Scientific Meetings

Dec 3, 2025, 8:22 AM EST - 1 day ago

Biodesix to Present New Data at Two Major Upcoming Scientific Meetings

Biodesix, Inc. (BDSX) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 10:46 PM EST - 4 weeks ago

Biodesix, Inc. (BDSX) Q3 2025 Earnings Call Transcript

Biodesix Announces Third Quarter 2025 Results and Highlights

Nov 3, 2025, 4:01 PM EST - 4 weeks ago

Biodesix Announces Third Quarter 2025 Results and Highlights

Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting

Oct 30, 2025, 6:17 AM EDT - 5 weeks ago

Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting

Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays

Oct 22, 2025, 6:17 AM EDT - 6 weeks ago

Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays

Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025

Oct 20, 2025, 6:00 AM EDT - 6 weeks ago

Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025

Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting

Oct 15, 2025, 6:09 AM EDT - 7 weeks ago

Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting

Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit

Oct 6, 2025, 10:13 AM EDT - 2 months ago

Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit

Biodesix Announces One-for-Twenty Reverse Stock Split

Sep 11, 2025, 8:00 AM EDT - 3 months ago

Biodesix Announces One-for-Twenty Reverse Stock Split

Biodesix to Participate in Lake Street Capital Markets' 9th Annual Best Ideas Growth (BIG9) Conference

Sep 5, 2025, 6:00 AM EDT - 3 months ago

Biodesix to Participate in Lake Street Capital Markets' 9th Annual Best Ideas Growth (BIG9) Conference

Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics

Aug 19, 2025, 9:47 AM EDT - 3 months ago

Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics

Biodesix, Inc. (BDSX) Q2 2025 Earnings Call Transcript

Aug 9, 2025, 11:07 AM EDT - 4 months ago

Biodesix, Inc. (BDSX) Q2 2025 Earnings Call Transcript

Biodesix Announces Second Quarter 2025 Results and Highlights

Aug 7, 2025, 4:06 PM EDT - 4 months ago

Biodesix Announces Second Quarter 2025 Results and Highlights

Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference

Aug 5, 2025, 6:00 AM EDT - 4 months ago

Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference

Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 24, 2025, 6:00 AM EDT - 4 months ago

Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025

Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation's First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs

Jun 10, 2025, 6:17 AM EDT - 6 months ago

Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation's First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs

Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting

May 22, 2025, 5:03 PM EDT - 7 months ago

Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting

Biodesix to Participate in Upcoming Investor Conferences

May 21, 2025, 6:00 AM EDT - 7 months ago

Biodesix to Participate in Upcoming Investor Conferences

Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS

May 15, 2025, 6:00 AM EDT - 7 months ago

Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS

Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award

May 14, 2025, 4:01 PM EDT - 7 months ago

Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award

Biodesix, Inc. (BDSX) Q1 2025 Earnings Call Transcript

May 13, 2025, 8:22 PM EDT - 7 months ago

Biodesix, Inc. (BDSX) Q1 2025 Earnings Call Transcript

Biodesix Announces First Quarter 2025 Results and Highlights

May 13, 2025, 4:01 PM EDT - 7 months ago

Biodesix Announces First Quarter 2025 Results and Highlights

Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025

Apr 29, 2025, 6:00 AM EDT - 7 months ago

Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025

Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types

Apr 23, 2025, 6:00 AM EDT - 8 months ago

Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types

Biodesix, Inc. (BDSX) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 8:06 PM EST - 9 months ago

Biodesix, Inc. (BDSX) Q4 2024 Earnings Call Transcript

Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results

Mar 3, 2025, 4:01 PM EST - 9 months ago

Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results

Biodesix to Present at TD Cowen 45th Annual Health Care Conference

Feb 26, 2025, 6:00 AM EST - 10 months ago

Biodesix to Present at TD Cowen 45th Annual Health Care Conference

Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Feb 18, 2025, 6:00 AM EST - 10 months ago

Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)

Jan 10, 2025, 6:00 AM EST - 11 months ago

Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)

Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study

Jan 7, 2025, 6:00 AM EST - 11 months ago

Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study

Biodesix, Inc. (BDSX) Q3 2024 Earnings Call Transcript

Nov 1, 2024, 3:29 PM EDT - 1 year ago

Biodesix, Inc. (BDSX) Q3 2024 Earnings Call Transcript

Biodesix Announces Third Quarter 2024 Results and Highlights

Nov 1, 2024, 6:00 AM EDT - 1 year ago

Biodesix Announces Third Quarter 2024 Results and Highlights

Biodesix to Participate in Three Investor Conferences in November

Oct 29, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Participate in Three Investor Conferences in November

Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024

Oct 18, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024

Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study

Oct 7, 2024, 6:00 AM EDT - 1 year ago

Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study

Biodesix to Present at Two Investor Conferences in September

Sep 5, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Present at Two Investor Conferences in September

Biodesix, Inc. (BDSX) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 8:52 PM EDT - 1 year ago

Biodesix, Inc. (BDSX) Q2 2024 Earnings Call Transcript

Biodesix Announces Second Quarter 2024 Results and Highlights

Aug 7, 2024, 4:01 PM EDT - 1 year ago

Biodesix Announces Second Quarter 2024 Results and Highlights

Biodesix to Present at Canaccord Genuity's 44th Annual Growth Conference

Aug 6, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Present at Canaccord Genuity's 44th Annual Growth Conference

Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024

Jul 24, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024

Biodesix Named to Inc. Magazine's 2024 “Best Workplaces”

Jun 18, 2024, 8:13 AM EDT - 1 year ago

Biodesix Named to Inc. Magazine's 2024 “Best Workplaces”

Biodesix to Participate in Two Investor Conferences in June

May 28, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Participate in Two Investor Conferences in June

Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting

May 21, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting

Biodesix, Inc. (BDSX) Q1 2024 Earnings Call Transcript

May 10, 2024, 1:06 AM EDT - 1 year ago

Biodesix, Inc. (BDSX) Q1 2024 Earnings Call Transcript

Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management

May 8, 2024, 4:01 PM EDT - 1 year ago

Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management

Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference

May 7, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference

Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024

Apr 24, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024

Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting

Apr 9, 2024, 5:00 PM EDT - 1 year ago

Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting

Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement

Apr 5, 2024, 7:17 AM EDT - 1 year ago

Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement

Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center

Mar 25, 2024, 6:00 AM EDT - 1 year ago

Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center

Crypto9999
Crypto9999 Dec. 3 at 5:21 PM
$BDSX *Ultra-small float under 4 mil shares * Insiders hold 52.1% * Shorts have been covering * Active roadshows, ie NACLC * Growing their salesforce * Potential Suitors: Thermo Fisher Scientific Roche Diagnostics QIAGEN Becton, Dickinson and company Labcorp A buyout could fetch a 5-10X plus from here....
0 · Reply
RogerBarfield374
RogerBarfield374 Dec. 3 at 1:33 PM
$BDSX Biodesix To Present Data On Development Of New Ultra-Sensitive ESR1 Test For Initial Detection And Monitoring Of Mutations In HR+/HER2- Advanced Breast Cancers At SABCS
0 · Reply
Iightning
Iightning Nov. 26 at 6:02 AM
1ightning® Options Trade Alert (Actionable) | Buy $BDSX Jan 16 $8 Call | Enter: $0.05 Exit: $0.08 | Profit: 67.96% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 4:10 PM
1ightning® Options Trade Alert (Actionable) | Buy $BDSX Jan 16 $8 Call | Enter: $0.05 Exit: $0.08 | Profit: 67.96% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 5:04 AM
1ightning® Options Trade Alert (Actionable) | Buy $BDSX Jan 16 $8 Call | Enter: $0.05 Exit: $0.08 | Profit: 67.96% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 22 at 2:15 AM
1ightning® Options Trade Alert (Actionable) | Buy $BDSX Jan 16 $8 Call | Enter: $0.05 Exit: $0.10 | Profit: 90.69% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 21 at 5:37 AM
1ightning® Options Trade Alert (Actionable) | Buy $BDSX Jan 16 $8 Call | Enter: $0.05 Exit: $0.10 | Profit: 90.69% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 20 at 3:31 AM
1ightning® Options Trade Alert (Actionable) | Buy $BDSX Jan 16 $8 Call | Enter: $0.05 Exit: $0.10 | Profit: 90.69% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 19 at 11:13 AM
1ightning® Options Trade Alert (Actionable) | Buy $BDSX Jan 16 $8 Call | Enter: $0.05 Exit: $0.10 | Profit: 90.69% ROI | https://1ightning.com
0 · Reply
NVDAMillionaire
NVDAMillionaire Nov. 18 at 6:52 AM
$BDSX Brilliant piece that captures BDSX's situation perfectly. So if you want to update your understanding of BDSX or get to know BDSX better, this is essential reading. https://beyondspx.com/quote/BDSX/analysis/biodesix-unlocking-lung-health-s-potential-on-a-path-to-profitability-nasdaq-bdsx
0 · Reply
Crypto9999
Crypto9999 Nov. 17 at 4:00 PM
$BDSX Once volume picks up.. $10+++🧲🧲🧲🧲
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 12 at 5:11 AM
Enter: $BDSX Calls Strike Price: $8 Expiry Date: JAN 16 2026 Buy in Price: $0.05 - $0.05 Sell Price: $0.07 Profit : +44% (Turn every $1 into $1.44) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 11 at 5:30 AM
Enter: $BDSX Calls Strike Price: $8 Expiry Date: JAN 16 2026 Buy in Price: $0.05 - $0.05 Sell Price: $0.08 Profit : +69% (Turn every $1 into $1.69) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 10 at 4:53 PM
Enter: $BDSX Calls Strike Price: $8 Expiry Date: JAN 16 2026 Buy in Price: $0.05 - $0.05 Sell Price: $0.09 Profit : +78% (Turn every $1 into $1.78) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 9 at 4:48 AM
Enter: $BDSX Calls Strike Price: $8 Expiry Date: JAN 16 2026 Buy in Price: $0.05 - $0.05 Sell Price: $0.09 Profit : +78% (Turn every $1 into $1.78) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 8 at 5:37 AM
Enter: $BDSX Calls Strike Price: $8 Expiry Date: JAN 16 2026 Buy in Price: $0.05 - $0.05 Sell Price: $0.08 Profit : +54% (Turn every $1 into $1.54) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 7 at 4:11 AM
Enter: $BDSX Calls Strike Price: $8 Expiry Date: JAN 16 2026 Buy in Price: $0.05 - $0.05 Sell Price: $0.09 Profit : +83% (Turn every $1 into $1.83) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 6 at 4:08 PM
Enter: $BDSX Calls Strike Price: $8 Expiry Date: JAN 16 2026 Buy in Price: $0.05 - $0.05 Sell Price: $0.08 Profit : +68% (Turn every $1 into $1.68) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
Vandenberg23
Vandenberg23 Nov. 6 at 12:58 PM
$BDSX Were we not told this company would be EBITA positive in 2025?
0 · Reply
GTMStox
GTMStox Nov. 6 at 1:07 AM
$BDSX Feeling like a lifeline of cash will be coming their way soon. Will be easy double from these levels. I would advise against being short.
1 · Reply
GTMStox
GTMStox Nov. 6 at 1:04 AM
$BDSX
0 · Reply
healthcareguru
healthcareguru Nov. 5 at 8:23 PM
$BDSX are you guys effing stupid?!? They’re out of cash and bankrupt in 4mos without another major raise… Back to <$5. 🤦‍♂️👎 $XLV $IWM $XBI
1 · Reply